Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy

Overview of attention for article published in Blood Cancer Discovery, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#38 of 183)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 2 news outlets
twitter: 44 tweeters

patent: 1 patent

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 48 Mendeley

Summary News Twitter Patents Dimensions citations

So far, Dimensions has found 42 publications that cite this research output.

42

The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.

SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?

Article in Hemato (May 2023)

Humoral and Cellular Responses to SARS-CoV-2 Vaccines Before and After Chimeric Antigen Receptor-Modified T Cell Therapy

Article in Blood Advances (April 2023)

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

Article in Frontiers in Immunology (April 2023)